
|Articles|September 1, 2004
Product preferencing tied to benefit design options
While plan managers have been doing it for nearly two decades with oral medications that are paid on the pharmacy benefit, the product-preferencing process is relatively novel for injectable medications. The next natural discussion is the role of benefit designs in the management of the cost of injectable products, since this is closely tied to product preferencing.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
LucyRx and Abarca to merge
2
Hospitals facing financial headwinds can't afford to ignore the mounting threats to 340B
3
FDA approves new sunscreen ingredient, first time in 20 years
4
Updated COVID-19 vaccine cut hospitalization risk by 35% in 2024-2025 season
5
































